news
Kadcyla new deal means NICE positive recommendation in draft guidance
A new deal on the breast cancer drug trastuzumab emtansine means that it can now be recommended for routine funding.
List view / Grid view
Data Analysis
news
BIA report shows UK on track to be world’s third global biotech cluster
A new report released by the UK BioIndustry Association (BIA) shows that the UK maintained its strong leadership position in European biotech funding last year and has the strongest pipeline in Europe for future drug development.
news
Health leaders launch Alliance for Transparent & Affordable Prescriptions
Health leaders announced the launch of the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the practices of pharmacy benefit managers (PBMs) driving up drug costs.
news
Drug costs vary by more than 600% in study of 10 high-income countries
In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories varied by more than 600%.
article
Risk, benefit or cost: What stops patients from receiving a diagnostic test?
Diagnostic tests can help identify disease and disease probability in patients, leading to earlier treatment, but what’s the real cost?
article
Why combatting cybercrime is critical for life science companies
Biotech and pharmaceutical firms hold vast amounts of valuable data and information making them prime targets for cyber-attacks – so how are they protecting themselves?
article
Improving healthcare professional engagement: Why quality customer data is key
10 April 2017 | By Guillaume Roussel, Director of Strategy, Veeva OpenData, Europe, Veeva Systems
Veeva's Guillaume Roussel explains how customer data can create personalised multichannel communication with healthcare professionals in the industry...
news
Thermo Fisher Scientific acquires Core Informatics
Thermo Fisher Scientific Inc., the world leader in serving science, announced that it has acquired Core Informatics, which provides a leading cloud-based platform supporting scientific data management.
article
Democratising clinical genomics while protecting data privacy
1 February 2017 | By Jurgi Camblong (CEO, Sophia Genetics)
Sophia Genetics co-founder and CEO, Jurgi Camblong, tackles issues of privacy and security for healthcare patient data...
article
Can you control your data? Preparing to comply with IDMP
22 November 2016 | By Monica McDonnell, Informatica
Informatica's Monica McDonnell gives the lowdown on the Identification of Medicinal Products new regulations and how to manage big data all across Europe...
article
Chemometrics: Implementing multivariate data analysis to monitor mammalian cell culture processes
13 June 2013 | By Payal Roychoudhury, formerly AstraZeneca and Ronan O’Kennedy, Fujifilm Diosynth Biotechologies and Jim Faulkner, GlaxoSmithKline and Brian McNeil & Linda M. Harvey, University of Strathclyde
Biopharmaceutical companies are constantly evaluating new methods for mammalian cell line development that offer benefits such as shorter time lines, improved consistency, higher monoclonal antibody (mAb) production, better genetic stability and increased flexibility. Each of these advantages extends a potentially large cost benefit to companies as their recombinant protein products…
news
Abbott introduces OneLab, a novel integrated Web-based software platform
As health care systems around the world face challenges such as labor shortages, increased regulation and budget constraints, they rely on technology to help manage the impact. To assist in addressing these challenges, today Abbott announced OneLab, a new, Web-based, integrated laboratory informatics solution.
article
Streamlining with automation and robotics
28 September 2006 | By Bart Hazes, Dept. of Medical Microbiology & Immunology, University of Alberta and Bernhard Rupp, q.e.d. life science discoveries, inc.
Protein crystallography has been embraced by the pharmaceutical industry to accelerate and rationalise the drug development process. In this role, success rates, throughput and turnaround times have become key competitive factors, and nearly every stage in the protein crystallography process has been targeted for automation using robotics and advanced software.…
